Perha Pharmaceuticals
Roscoff
About Perha Pharmaceuticals
Perha Pharmaceuticals is a biotechnology company that specializes in the research and development of kinase inhibitors. The company's investigation begins with natural marine substances. Indeed, some of the molecules optimized by Perha Pharmaceuticals' chemists and biologists are derived from natural products isolated from marine organisms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Funding stage: Seed
- Last round: Seed (Mar 2022)
- Website: perha-pharma.fr
- Phone: 0608605834
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/perha-pharmaceuticals-67447 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.